The Asia Pacific Healthcare contract research organizations (CRO) services market is expected to reach US$ 16,745.94 million by 2027 from US$ 7,559.03 million in 2019; it is estimated to grow at a CAGR of 10.6% from 2020 to 2027.
The growth of the Asia Pacific healthcare contract research organizations (CRO) services market is mainly attributed as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the country. However, the dearth of skilled professional is the major factor hindering the market growth in Asia Pacific.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Clinical trials play a determinant role in drug approvals and its efficacy over diseases. The studies help in understanding the best medical approaches in certain therapeutic areas. The healthcare systems are observing a rapid increase in the number of clinical trials. Factors such as growing demand for novel drugs and medical equipment, increasing prevalence of chronic conditions, and growth in funding programs to conduct clinical trials are responsible for propelling the number of clinical trials.
With the consistent and growing demand for clinical trials worldwide, geographic expansion into Asia continues at a steady pace. The need for Asia as a region for clinical trial conduct and clinical trial sites is a result of both the competitive landscape for patients as well as a diversification among sponsor companies to file new drug applications in the Asian markets, requiring local trials and patients. China represents one of the largest potential growth regions for clinical trials and CRO market in the next five years if the CFDA reforms are enacted and start-up timelines decrease significantly. The access to large numbers of patients, both disease-specific and treatment naïve, in urban settings will continue to make China attractive for trials. The remaining Southeast Asian countries (Malaysia, Philippines, Cambodia, Vietnam, Myanmar, Thailand, Laos, Indonesia) all represent a small number of active clinical trial sites. However, with respect to populations and access to treatment naïve patients, as well as certain therapeutic indications (tropical disease, infectious disease, certain cancers), these countries present excellent growth opportunities for CROs. Although the cost of conducting clinical trials in Asia is significantly lower. The outsourcing penetration in Japan is just 20% compared to ~50% in the US, so there is significant room for growth.
Asia Pacific countries are expecting to witness massive challenges due to increasing COVID-19. Prohibitory measures have been taken to control the spread of this pandemic. However, in this measure, hospitals, clinics, diagnostic centers, ambulatory surgery centers (ASCs) not taking any general patient on priority. Apart from the overall health system, healthcare contract research organizations (CRO) services have been facing challenges due to coronavirus outbreak. Thus, such cancellations of studies is likely to negatively affect the growth of the market.
Rest of Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET SEGMENTATION
By Service Type
- Early Phase Development
- Laboratory Services
- Consulting Services
- Clinical Research Services
By Therapeutic Application
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End-User
- Medical Device Companies
- Pharmaceutical and Biopharmaceutical Companies
- Others (Academic Institutes)
By Country
- Japan
- China
- South Korea
- India
- Australia
Company Profiles
- Wuxi AppTec
- IQVIA INC
- Laboratory Corporation of America Holdings (Covance)
- PRA Health Sciences
- Syneos Health
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Asia Pacific Healthcare Contract Research Organizations Services Market Forecast to 2027 - COVID-19 Impact and Regional Analysis byService Type, Therapeutic Indication, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Healthcare contract research organizations (CRO) services Market – By Service Type
1.3.2 Asia Pacific Healthcare contract research organizations (CRO) services Market – By Therapeutic Indication
1.3.3 Asia Pacific Healthcare contract research organizations (CRO) services Market – By End User
1.3.4 Asia Pacific Healthcare contract research organizations (CRO) services Market – By Country
2. Asia Pacific Healthcare contract research organizations (CRO) services Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Healthcare contract research organizations (CRO) services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Healthcare contract research organizations (CRO) services Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Healthcare Contract Research Organizations (CRO) services Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Expenditure in R&D and Outsourcing Activities
5.1.2 Rising Number of Clinical Trials
5.2 Key Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Biosimilars and Biologics Market
5.4 Future Trends
5.4.1 Advancement of Technology in Research Field
5.5 Impact Analysis
6. Healthcare Contract Research Organizations (CRO) Services Market – Asia Pacific Analysis
6.1 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecasts and Analysis
7. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Analysis and Forecasts To 2027 – By Service Type
7.1 Overview
7.2 Asia Pacific Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%)
7.2.1 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027, By Service Type (US$ Mn)
7.2.2 Clinical-Research Services Market Revenue and Forecasts to 2027 (US$ Million)
7.2.3 Early Phase Development Market Revenue and Forecasts to 2027 (US$ Million)
7.2.4 Laboratory Services Market Revenue and Forecasts to 2027 (US$ Million)
7.1 Early Phase Development
7.1.1 Overview
7.1.2 Asia Pacific Early Phase Development Market Revenue and Forecast to 2027 (US$ Mn)
7.1.3 Discovery Studies
7.1.3.1 Overview
7.1.3.2 Asia Pacific Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4 Chemistry, Manufacturing, and Control
7.1.4.1 Overview
7.1.4.2 Asia Pacific Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5 Pre-Clinical Services
7.1.5.1 Overview
7.1.5.2 Asia Pacific Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.2 Laboratory Services
7.2.1 Overview
7.2.2 Asia Pacific Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.2.3 Bio-analytical Testing
7.2.3.1 Overview
7.2.3.2 Eur ope Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
7.2.4 Analytical Testing
7.2.4.1 Overview
7.2.4.2 Asia Pacific Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
7.3 Consulting Services
7.3.1 Overview
7.3.2 Asia Pacific Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Clinical Research Services
7.4.1 Overview
7.4.2 Asia Pacific Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Phase I
7.4.3.1 Overview
7.4.3.2 Asia Pacific Phase I Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Phase II
7.4.4.1 Overview
7.4.4.2 Asia Pacific Phase II Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Phase III
7.4.5.1 Overview
7.4.5.2 Asia Pacific Phase III Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.6 Phase IV
7.4.6.1 Overview
7.4.6.2 Asia Pacific Phase IV Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Therapeutic Application
8.1 Overview
8.2 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, By Therapeutic Application 2019-2027 (%)
8.2.1 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Devices Revenue and Forecasts to 2027, By Therapeutic Application (US$ Mn)
8.3 Oncology
8.3.1 Overview
8.3.2 Asia Pacific Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Infectious Diseases
8.4.1 Overview
8.4.2 Asia Pacific Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Asia Pacific Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Asia Pacific Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Neurological Disorders
8.7.1 Overview
8.7.2 Asia Pacific Neurological Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Healthcare contract research organizations (CRO) services Market Analysis – By End User
9.1 Overview
9.2 Asia Pacific Healthcare contract research organizations (CRO) services Market, By End User 2019-2027 (%)
9.2.1 Asia Pacific Healthcare contract research organizations (CRO) services Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Asia Pacific Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Medical Device Companies
9.4.1 Overview
9.4.2 Asia Pacific Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Others (Academic Institutes)
9.5.1 Overview
9.5.2 Asia Pacific Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn)
10. Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1.1 Asia Pacific: Healthcare Contract Research Organizations (CRO) Services Market-Revenue and Forecasts to 2027 (US$ Million)
10.1.2 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.2.1 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.2.2 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.2.3 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%)
10.1.6 Japan Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 Japan Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7 Japan Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Japan Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Japan Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Japan Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.9 Japan Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.10 China Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 China Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11 China Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 China Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 China Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 China Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.12 China Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.13 China Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.14 South Korea Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.14.1 South Korea Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.15.1 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.15.2 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.15.3 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.16 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.17 South Korea Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.18 India Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.18.1 India Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.19 India Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.19.1 India Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.19.2 India Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.19.3 India Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.20 India Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.21 India Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.22 Australia Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.22.1 Australia Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.23 Australia Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million)
10.1.23.1 Australia Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million)
10.1.23.2 Australia Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
10.1.23.3 Australia Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
10.1.24 Australia Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million)
10.1.25 Australia Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Healthcare contract research organizations (CRO) services Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 WuXi AppTec
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 IQVIA INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corporation of America Holdings (Covance)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PRA Health Sciences
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Syneos Health
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Service Type (US$ Mn)
Table 2. Clinical-Research Services Market Revenue And Forecasts to 2027 (US$ Million)
Table 3. Early Phase Development Market Revenue And Forecasts to 2027 (US$ Million)
Table 4. Laboratory Services Market Revenue And Forecasts to 2027 (US$ Million)
Table 5. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Therapeutic Application (US$ Mn)
Table 6. Asia Pacific Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 7. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 8. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 9. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 10. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 11. Asia Pacific Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 12. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Japan Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 14. Japan Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 15. Japan Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 16. Japan Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 17. Japan Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 18. Japan Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. China Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 20. China Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 21. China Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 22. China Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 23. China Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 24. China Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 25. South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 26. South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 27. South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 28. South Korea Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. India Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 32. India Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 33. India Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 34. India Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 35. India Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 36. India Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. Australia Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Australia Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million)
Table 39. Australia Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million)
Table 40. Australia Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million)
Table 41. Australia Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million)
Table 42. Australia Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 43. Glossary of Terms, Healthcare Contract Research Organizations (CRO) Services Market
LIST OF FIGURES
Figure 1. Healthcare contract research organizations (CRO) services Market Segmentation
Figure 2. Asia Pacific Healthcare contract research organizations (CRO) services Market Overview
Figure 3. Clinical Research Services Segment Held Largest Share of Healthcare Contract Research Organizations (CRO) Services Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Healthcare contract research organizations (CRO) services Market - Leading Country Markets (US$ Mn)
Figure 6. Healthcare contract research organizations (CRO) services Market - Asia Pacific PEST Analysis
Figure 7. Healthcare contract research organizations (CRO) services Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Healthcare Contract Research Organizations (CRO) Services market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%)
Figure 10. Asia Pacific Early Phase Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Phase I Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Phase II Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Phase II Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Phase IV Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Application 2019 & 2027 (%)
Figure 24. Asia Pacific Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Asia Pacific Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Asia Pacific Neurological Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia Pacific Healthcare contract research organizations (CRO) services Market, by End User 2019 & 2027 (%)
Figure 31. Asia Pacific Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Asia Pacific Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Asia Pacific Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue, by Country, 2019 (US$ Mn)
Figure 35. Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Million)
Figure 36. Asia Pacific: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%)
Figure 37. Japan Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. China Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. South Korea Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. India Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Australia Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Wuxi AppTec
- IQVIA INC
- Laboratory Corporation of America Holdings (Covance)
- PRA Health Sciences
- Syneos Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Healthcare Contract Research Organizations (CRO) Services Market
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)